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Abstract 
The aim of this article is to use data from Belgium to analyse distinctions between 
palliative sedation and euthanasia. There is a need to reduce confusion and improve 
communication related to patient management at the end of life specifically 
regarding the rapidly expanding area of patient care that incorporates a spectrum of 
nuanced yet overlapping terms such as palliative care, sedation, palliative sedation, 
continued sedation, continued sedation until death, terminal sedation, voluntary 
euthanasia and involuntary euthanasia. Some physicians and nurses mistakenly think 
that relieving suffering at the end of life by heavily sedating patients is a form of 
euthanasia, when indeed it is merely responding to the ordinary and proportionate 
needs of the patient. Concerns are raised about abuse in the form of deliberate 
involuntary euthanasia, obfuscation and disregard for the processes sustaining the 
management of refractory suffering at the end of life. Some suggestions designed to 
improve patient management and prevent potential abuse are offered. 
The published version is available at http://dx.doi.org/10.1136/bmjspcare-2017-001398 
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Introduction 
The central premise of this manuscript is that the appropriate and measured use of 
sedation at the end of life to help reduce human suffering can transition into 
confusing and problematic care because of three main reasons. First, physicians 
understand different practicesas being complicit with ‘euthanasia’. This confusion in 
terminology hampers effective monitoring and control over the practice of 
euthanasia.1  Second, there is ambiguity and uncertainty regarding physicians’ 
intentions in administrating sedation. There is a grey area between sedation 
intended only to relieve suffering versus sedation deliberately intended to hasten 
death.2–4  Third, as a result of the above problems, the use of sedation is opened to 
abuse. Abuse of sedation occurs when clinicians sedate patients at the end of their 
lives with the primary goal of hastening and causing the patient’s death.5–7 
Continuous deep sedation until death might be initiated without consent or request 
of either the patient or the family. One study showed that in the case of 1200 
patients in Belgium, the intention of the medical team was explicitly to shorten life.8 
This is inappropriate use of sedation. Explicit life-shortening intentions are reported 
by physicians.9–11  Administration of medication with the covert intention to hasten 
death is ethically wrong.5 6 12–16 
This article clarifies the terminology and explains why palliative sedation is not 
euthanasia (as euthanasia rests on intent to end life), and why it is important to be as 
precise as possible in applying the right terminology in describing different practices 
at the end of life. We use data from Belgium to present a discussion that will help 
others avoid communication and end-of-life management pitfalls in this confusing 
area of medical practice. It is argued that in too many instances, Belgian physicians 
are obfuscating palliative sedation in order to euthanise patients with their consent or 
to deliberately hasten patient deaths often without any process of consent. Finally, 
we make some constructive suggestions aimed at serving the patients’ best 
interests, preventing abuse and improving decision-making processes at the end of 
life. 
The Belgian Euthanasia Act and sedation 
Euthanasia is defined as the act, performed by a third party, which intentionally ends 
the life of a person at his or her explicit request. The legislation lays out the terms for 
doctors to end the lives of patients who are in a state which, medically, is without 
prospect of improvement.17  Euthanasia requests are approved only if the patient is in 
a hopeless medical condition and complains of constant and unbearable physical or 
mental pain which cannot be relieved and is the result of a serious and incurable 
accidental or pathological condition. At least 1 month must elapse between the 
written request and the mercy killing.18 The 1 month stipulation is required only 
when the patient is not ‘terminally ill’ (eg, quadriplegia). Since the enactment of the 
Euthanasia Act in 2002, reports are being published by the Belgian 
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Federal Control and Evaluation Commission, established by the government in 
September 2002, assigned to monitor the law’s application. A constant increase in 
registered euthanasia cases has been observed, predominantly in the Flemish (the 
Dutch-Flemish speaking) part of Belgium.19–21  Johan Bilsen et al found that the 
enactment of the Euthanasia Act in Belgium was followed by an increase in almost 
all types of medical end-of-life practices: euthanasia, intensified alleviation of pain, 
withholding or withdrawing life-prolonging treatment, and continuous and deep 
sedation until death.20 22  i 
Many Belgian scholars tend to cluster together practices under broad categories 
such as End-of-Life Decisions1 23 and Life-Ending Acts Without Explicit Request.24  25 
This clustering creates a false continuum between palliative care and euthanasia. 
Furthermore, Belgian researchers describe the practice of slowly increasing the 
dosage of sedatives while gradually withdrawing treatment in different 
terms: continuous sedation,26 27 continued sedation to unconsciousness,28  continuous 
deep sedation,29 continuous sedation at the end of life,26 27 30 continuous sedation until 
death,31continuous deep sedation until death,9 palliative sedation and terminal 
sedation.28 32 ,ii These terms are often used interchangeably, which adds to the 
confusion. 
Clarifications 
Palliative care 
This refers to the active, comprehensive and total care of patients whose disease is 
not responsive to curative treatment, where maintaining the control of pain and 
other sources of suffering (eg, anxiety, psychological, social and spiritual problems) 
is paramount. Palliative care is action by the medical community to optimise the 
comfort, function, relationships, healing, dignity and preparation for the death of 
the person, who has life-threatening illness, and their family.33 34 
Palliative sedation 
This is the use of sedative medication to relieve intolerable suffering during a 
patient’s active dying process by a reduction of the patient’s level of 
consciousness.35–37  To be clear, euthanasia involves administering deliberately lethal 
doses of barbiturates and paralytic agents. In contrast, palliative sedation involves 
administration of potent psychoactive medications such as opioids, antipsychotics, 
benzodiazepines or propofol (intravenous, oral or subcutaneous) in a manner 
proportionate to prevailing symptoms to accomplish relief of suffering with mild, 
moderate or deep sedation.38 39 Opioids are used for alleviating pain and/or refractory 
dyspnoea. Shortness of breath causes great suffering and opioids can help patients; 
thus palliation with opioids is appropriate up to a point. If used to help 
palliate suffering, this is ethically sound. If consciously used and intentionally used to 
stop breathing entirely and kill the patient, this is unethical. At any rate, shortening 
life is not the explicit or implicit intent of palliative sedation. 
A significant minority of dying people (cancer research indicates between a tenth and 
a quarter) experience refractory symptoms such as fatigue, dyspnoea, pain, 
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anxiety and nausea, or extreme distress unresponsive to conventional therapies. In 
such circumstances, sedation may be used to decrease or remove 
consciousness.28  According to members of the Department of Intensive Care, 
Erasme Hospital in Brussels, sedation is encouraged to keep patients calm, 
collaborative and comfortable. Patients with severe respiratory failure received 
sedatives for the longest duration, followed by postoperative and 
haemodynamically  unstable patients.40 
While euthanasia shortens life, palliative sedation does not shorten life.41 Maltoni et 
al argued that palliative sedation, when appropriately indicated and correctly used to 
relieve unbearable suffering, does not have any detrimental effect on survival of 
patients with terminal cancer.42 43 Palliative sedation may even prolong life to some 
extent because it prevents exhaustion as a result of suffering.44 In Temel’s landmark 
trial of patients with metastatic non-small cell lung cancer, as compared with usual 
care, those randomised to early palliative care led to significant improvements in 
both quality of life and mood with less aggressive care at the end of life yet longer 
survival.45 
Continuous sedation 
Anquinet et al define continuous sedation as the practice where sedation, that is, the 
lowering of the patient’s consciousness, is administered continuously until the time 
of death. The authors explain that this practice can only be performed when the 
patient has a very limited life expectancy and that it does not aim at the death of the 
patient.46 This definition lumps together continuous sedation and continuous sedation 
until death. Other scholars use the short and imprecise acronym CS 
for continuous sedation at the end of life.26 47 In another article, Belgian scholars resort 
to yet another term, continuous deep sedation (CDS) to describe the same practice.29  
Some of these scholars, together with others, use another acronym, CSD, to 
describe the same phenomenon, this time calling it continuous sedation until death.31 
In his comments on this article, Kasper Raus explained that ‘continuous sedation’ is 
the broad concept that includes both light and deep sedation while ‘continuous deep 
sedation’ is a particular form of continuous sedation, namely that form where the 
patient is deeply sedated. But this is not clear in the article. It is also unclear whether 
the ‘continuous deep sedation’ patient group is different (smaller?) from the 
‘continuous sedation’ patient group. 
Terminal sedation 
The term terminal sedation, which we believe is confusing regarding clinical intent, 
was introduced by Enck in a 1991 review article published in the American Journal of 
Hospice and Palliative Care.48 Since then, terminal sedation has been a widely used 
term, although the term plays only a marginal role in most other international 
clinical studies.49 Chater et al examined the response of 61 selected palliative care 
experts to a proposed definition for terminal sedation. The experts opined that the 
term ‘terminal sedation’ should be abandoned and be replaced with another such as 
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palliative sedation.50  Several other authors object to the use of the term terminal 
sedation.51–53 
The practice of sedating patients until death, while is clinically appropriate in some 
patients, is significantly more prevalent in Belgium than euthanasia. A study among 
six European countries (Belgium, Denmark, Italy, The Netherlands, Sweden and 
Switzerland) with comparative epidemiology of terminal disease showed that 
Belgium had the second highest percentage of continuous deep sedation,54 also 
termed continuous and deep sedation until death20 55: 8.2% of all deaths. The report 
on continuous deep sedation until death conducted in Flanders in 2007 showed that 
14.5% of all deaths occurred while using this practice. This is a significant increase 
compared with 8.2%, just 6 years earlier.20 56 57 
One definite downside of such deep sedation is that it usually results in a fairly 
profound drug-induced delirium, which is certainly a form of suffering that many 
describe as torturous. The hazard of such a drug-induced delirium is that profound 
cognitive dysfunction deprives some otherwise competent and lucid patients of very 
meaningful and desired periods of communication with loved ones, 
spiritually focused interactions and relationship reconciliation. Drug-induced delirium 
is often idiosyncratic in nature and there is a great degree of interindividual 
variability with regard to how often and how long a patient’s drug-induced delirium 
lasts.58 The diagnosis is easily missed unless clinicians maintain a high index of 
suspicion. Indeed, three out of four patients experiencing delirium will be missed by 
healthcare professionals unless they use validated clinical tools.59–62 This is because 
the patients are usually experiencing a brain dysfunction that is called hypoactive or 
‘quiet’ delirium, which is manifested by negative symptoms such as the inability to 
pay attention and disorganised thinking. 
Suggestions for improvement 
We recommend that the broad terminology brush that is quite often used in 
referring to various end-of-life practices be replaced with one that clearly defines 
each practice and explains how that particular practice is different than other 
practices. The refined, specific, and detailed brush will help in avoiding confusion 
and in explaining various options that are available in treating patients in the last 
stage of their lives. This issue is of utmost importance as language has significant 
effects on reality. Unclear terminology leads at best to confusion and at worst to 
abuse, obfuscation and disregard for the processes underpinning the ethical 
administration of sedation in the management of refractory suffering at the end of 
life. 
The Belgian Advisory Committee on Bioethics should agree on the relevant 
definitions and adhere to them so all people, including scholars, physicians and 
nurses, know when they are speaking about the same practice. According to 
Broeckaert et al, 'palliative sedation is the intentional administration of sedative 
drugs in dosages and combinations required to reduce the consciousness of a terminal 
patient as much as necessary to adequately relieve one or more refractory 
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symptoms’.63 64 Chambaere et al, on the other hand, use a narrower and more 
general definition of palliative sedation in their survey, namely ‘the use of one or 
more drugs to keep the patient deeply sedated or in a coma until 
death’.65 Chambaere et al’s definition does not refer to the physician’s intention and 
instead of reducing consciousness it speaks of ‘coma until death.’ All the 
qualifications in Broeckaert et al’s definition that accentuate adequate and 
proportional palliative sedation in accordance with the patient’s medical condition 
are missing from Chambaere et al’s definition. This represents the sort of ‘drift’ in 
terminology that is potentially so hazardous. 
The Belgian ‘Palliative Sedation Directive’ guidelines are of importance.66  67 Because 
sedation diminishes the patient’s ability to interact with his or her surroundings, it 
should be done judiciously and carefully. This directive for the use of palliative 
sedation includes the presence of refractory physical, psychological and/or  existential 
suffering; the drugs that should be used; the need for communication  with patients 
and their families; and good control mechanisms. The directive explains the meaning 
of physical and psychological refractory symptoms. It instructs that the dosages and 
combinations to be administered should be proportional to the specific patient’s 
condition, aiming to alleviate suffering; consultation with patient and relatives should 
be sought. The medical team should strive to have the best possible communication 
with patients and their families. When a patient is competent, the informed consent 
of the patient should be secured. Emphasis is put on monitoring, instructing to ensure 
that all relevant information relating to patients, their condition, the decision to 
administer palliative sedation, the 
prescription for the implementation, evaluation and any adjustments to the dose are 
defined in the patients’ medical files. Also, it is important to remember that if 
clinically appropriate and judged in the patient’s best interest and in accordance to 
his/her preferences, palliative sedation can be reversed or stopped. Should clinical 
circumstances change qualitatively or quantitatively, the drugs can be stopped to 
allow the patient to communicate better with the loved one or clinical team. 
Because this Palliative Sedation Directive is relatively new, it is likely that many 
medical professionals are unaware of its specifications. It is recommended to employ 
clear terminology by elucidating the differences between euthanasia and palliative 
sedation. The ethical dimensions of the practices (autonomy, consent, 
proportionality of treatment, goals of treatment) have direct, practical implications 
on the patient’s treatment. Medical records should include detailed documentation 
relating to the medical condition, patient’s wishes, discussions with the patient 
and/or her loved ones, treatment decisions including the use of palliation, the use of 
artificial hydration when appropriate and the effects of the intervention. 
According to the Belgian Palliative Sedation Directive, sedation can be used for 
patients with a life expectancy of a few days up to 1 week.66 67 The 2014 Deyaert et al 
study is disconcerting because it shows that physicians had shortened lives although 
they estimated that the patients could have lived longer than 1  week in 
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6.4 % of the cases, and in almost 80% of cases they did not secure the patient’s 
consent.23  Chambaere et al noted that in some cases alternatives to sedation had 
been possible for the treatment of symptoms and that continuous deep sedation 
would then be ethically questionable.56 
Palliative sedation in the terminal stage of a patient’s life requires a specialist’s 
knowledge. Oftentimes, a critical care team consults an expert in palliative care 
when deciding to embark on such a path of treatment.iii 68 Such a consultation can 
improve the quality of the decision-making process, provide insights that non- 
experts may lack and is likely to serve the patient’s best interests in providing the 
optimum care at the end of life.66 67 
Broeckaert et al argue that the palliative care knowledge and expertise of the 
average physician is very limited. Most physicians have little training in palliative 
sedation or no training at all. Broeckaert et al maintain that at their own Catholic 
University of Leuven, the number of cases of palliative sedation had dropped from 
7% in the first year of the palliative care unit (1999–2000) to an annual rate of 1%– 
2% since 2001.69 Patients and their loved ones should be counselled about the 
patient’s condition, available options for treatment, contingency plans and 
implications of induced unconsciousness so as to enable them to make their 
preferred choice. Open discussions should be held with the medical team 
accentuating that sedation should not be used as a short cut, instead of providing 
comprehensive palliative care to the patient, including spiritual and emotional 
support. Belgian experts recommended that interdisciplinary team approaches, 
involving physicians, nurses, physiotherapists and pharmacists are needed to 
optimise sedative management. Unfortunately, they noted that these measures have 
not been widely incorporated into practice.40  More interdisciplinary studies and work 
are required. 
 
Conclusions 
The differences between palliative sedation and euthanasia should be explained, 
clarified and elucidated, relating to patient’s consent and autonomy, the 
performance of the two practices and the explicit legal directives for euthanasia. 
Open discussions should be held about the decision-making process and who should 
be involved in it. Physicians may also benefit from discussion on decision-making 
processes and the appropriate use of opioids and other medications that might 
shorten life. 
The alarming and documented (though under-reported) problem of many thousands 
of patients being treated by physicians who intentionally hasten death without the 
patient’s consent should be addressed. In 2007, the use of life-ending drugs with the 
intention to shorten life and without explicit request occurred in 1.8% of deaths70 and 
in 2013 it was 1.7% of deaths.22 71Sometimes it is clear from reports that there was no 
surrogate or proxy consent, and sometimes this issue is omitted. Since those in a 
terminal state or conditions of intractable suffering are frequently 
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unable to consent, the issue is important. If proxy consent was garnered, it is a very 
different issue than if consent was not attempted or unsuccessfully obtained from the 
patient or his/her surrogate. Details should be provided and data meticulously tracked in 
this area. 
Defenders of the Belgian policy and practices at the end of life argue that the Belgian 
model is ‘a well-functioning experiment and probably a prototype of things to come 
elsewhere’.24  We disagree with regard to the first half of the statement and voice hope 
that the Belgian model will not become a prototype of things to come elsewhere. 
Supporters of the Belgian model argue that they have one of the best palliative care 
systems in the world, while research points, time and again, to severe deficiencies and 
abuses. Recent research regarding the use of quality indicators in palliative care shows 
that there are many barriers in the implementation of quality measurement such as lack 
of time and skills, the need for good leadership, the need for quality training and the 
need to learn from other services in the field. The researchers recommended the 
development of a process evaluation plan to assess the quality of the implementation 
process and the effectiveness of the palliative care strategies. Throughout the whole 
implementation process, involvement of stakeholders should be retained to evaluate 
critically the progression towards a systematic quality monitoring system of palliative 
care provided to patients.72 
The Belgian attitude to end-of-life care has become too lax. Given that ending patients’ 
lives without request is more common than euthanasia,73  and the significant number of 
palliative and/or terminal sedation cases, the need for equipping healthcare providers with 
adequate education and training is  accentuated. As shown, research conducted in Belgium 
does not convince that its physicians have the awareness and knowledge of the different 
types of sedation and how they differ from euthanasia. The Belgians are researching the 
way their dying patients are being handled in a medical context. Their culture of self-
searching is certainly necessary. They need to develop the policy and means to assure that 
patients receive quality of care that serve the patients’ best interests. 
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